Second malignancies following CMF-based adjuvant chemotherapy in resectable breast cancer

Annals of Oncology

Volumn 5, Issue 9, 1994, Pages 803-808

  Valagussa, P ^a   Moliterni, A ^a   Terenziani, M ^a   Zambetti, M ^a   Bonadonna, G ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Adjuvant chemotherapy; Operable breast cancer; Second malignancies

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; METHOTREXATE;

ADJUVANT CHEMOTHERAPY; ADULT; ARTICLE; BREAST CANCER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SECOND CANCER;

EID: 0028125146     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.annonc.a059008     Document Type: Article

References (0)